Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats

British Journal of Pharmacology

Volumn 146, Issue 3, 2005, Pages 315-323

  Gaskari, Seyed Ali ^a   Liu, Hongqun ^a   Moezi, Leila ^a   Li, Yang ^a   Soon, Koo Baik ^a   Lee, Samuel S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cirrhosis; Endocannabinoids; Force frequency; Heart; Papillary muscle; Rat

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; ENDOCANNABINOID; ISOPRENALINE; MESSENGER RNA; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; PERTUSSIS TOXIN; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CARDIOMYOPATHY; CIRRHOTIC CARDIOMYOPATHY; CONTROLLED STUDY; DOSE RESPONSE; FORCE; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART PAPILLARY MUSCLE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TACHYCARDIA; WESTERN BLOTTING;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; BILE DUCTS; CARDIOMYOPATHIES; GENE EXPRESSION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MYOCARDIAL CONTRACTION; PAPILLARY MUSCLES; PERTUSSIS TOXIN; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRODOTOXIN; VENTRICULAR FUNCTION, LEFT;

EID: 27144472559     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706331     Document Type: Article

References (46)

1. BATKAI, S., JARAI, Z., WAGNER, J.A., GOPARAJU, S.K., VARGA, K., LIU, J., WANG, L., MIRSHAHI, F., KHANOLKAR, A.D., MAKRIYANNIS, A., URBASCHEK, R., GARCIA JR, N., SANYAL, A.J. & KUNOS, G. (2001). Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat. Med., 1, 827-832.
2. BELTRAMO, M., STELLA, N., CALIGNANO, A., LIN, S.Y., MAKRIYANNIS, A. & PIOMELLI, D. (1997). Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science, 277, 1094-1097.
3. BERNARDI, M., RUBBOLI, A., TREVISANI, F., CANCELLIERI, C., LIGABUE, A., BARALDINI, M. & GASBARRINI, G. (1991). Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis. J. Hepatol., 12, 207-216.
4. BIFULCO, M., LAEZZA, C., VALENTI, M., LIGRESTI, A., PORTELLA, G. & DI MARZO, V. (2004). A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. FASEB J., 18, 1606-1608.
5. BONZ, A., LASER, M., KULLMER, S., KNIESCH, S., BABIN-EBELL, J., POPP, V., ERTL, G. & WAGNER, J.A. (2003). Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle. J. Cardiovasc. Pharmacol., 41, 657-664.
6. CAMPBELL, F., ATWELL, R., FENNING, A., HOEY, A. & BROWN, L. (2004). Cardiovascular effects of the toxin(s) of the Australian paralysis tick, Ixodes holocyclus, in the rat. Toxicon, 43, 743-750.
7. CARAMELO, C., FERNANDEZ-MUNOZ, D., SANTOS, J.C., BLANCHART, A., RODRIGUEZ-PUYOL, D., LOPEZ-NOVOA, J.M. & HERNANDO, L. (1986). Effect of volume expansion on hemodynamics, capillary permeability and renal function in conscious, cirrhotic rats. Hepatology (Baltimore, MD), 6, 129-134.
8. CHRISTOPOULOS, A., COLES, P., LAY, L., LEW, M.J. & ANGUS, J.A. (2001). Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens. Br. J. Pharmacol., 132, 1281-1291.
9. DE PETROCELLIS, L., BISOGNO, T., DAVIS, J.B., PERTWEE, R.G. & DI MARZO, V. (2000). Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett., 483, 52-56.
10. DI MARZO, V., BISOGNO, T. & DE PETROCELLIS, L. (2001). Anandamide: some like it hot. Trends Pharmacol. Sci., 22, 346-349.
11. DOMENICALI, M., ROS, J., FERNANDEZ-VARO, G., CEJUDO-MARTIN, P., CRESPO, M., MORALES-RUIZ, M., BRIONES, A.M., CAMPISTOL, J.-M., ARROYO, V., VILA, E., RODES, J. & JIMENEZ, W. (2005). Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. Gut, 54, 522-527.
12. FORD, W.R., HONAN, S.A., WHITE, R. & HILEY, C.R. (2002). Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. Br. J. Pharmacol., 135, 1191-1198.
13. FOWLER, C.J., TIGER, G., LIGRESTI, A., LOPEZ-RODRIGUEZ, M.L. & DI MARZO, V (2004). Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis - a difficult issue to handle. Eur. J. Pharmacol., 492, 1-11.
14. GIFFORD, A.N., BRUNEUS, M., GATLEY, S.J. & VOLKOW, N.D. (2000). Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes. Br. J. Pharmacol., 131, 645-650.
15. GROSE, R.D., NOLAN, J., DILLON, J.F., ERRINGTON, M., HANNAN, W.J., BOUCHIER, I.A.D. & HAYES, P.C. (1995). Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J. Hepatol., 22, 326-332.
16. HAYES, B.E., WILL, J.A., ZARNSTORFF, W.C. & BISGARD, G.E. (1984). Limitations of thermodilution cardiac output measurements in the rat. Am. J. Physiol., 246, H754-H760.
17. HONERJAGER, P. (1982). Cardioactive substances that prolong the open state of sodium channels. Rev. Physiol. Biochem. Pharmacol., 92, 1-74.
18. INGLES, A.C., HERNANDEZ, I., GARCIA-ESTAN, J., QUESADA, T. & CARBONELL, L.F. (1991). Limited cardiac preload reserve in conscious cirrhotic rats. Am. J. Physiol., 260, H1912-H1917.
19. JARRAHIAN, A., MANNA, S., EDGEMOND, W.S., CAMPBELL, W.B. & HILLARD, C.J. (2000). Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. J. Neurochem., 74, 2597-2606.
20. KISSLING, G., ROSS, C. & BRANDLE, M. (1993). Validity of thermal dilution technique for measurement of cardiac output in rats. Am. J. Physiol., 265, H1007-H1013.
21. LEE, S.S. (2003). Cardiac dysfunction in spontaneous bacterial peritonitis: a manifestation of cirrhotic cardiomyopathy? Hepatology. 38, 1089-1091.
22. LEWIS, R.J. & ENDEAN, R. (1986). Direct and indirect effects of ciguatoxin on guinea-pig atria and papillary muscles. Naunyn Schmiedebergs Arch. Pharmacol., 334, 313-322.
23. LIU, H. & LEE, S. (1999). Cardiopulmonary dysfunction in cirrhosis. J. Gastroenterol. Hepatol., 14, 600-608.
24. LIU, H., MA, Z. & LEE, S.S. (2000). Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology, 118, 937-944.
25. LIU, H., SONG, D. & LEE, S.S. (2001). Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat. Am. J. Physiol. Gastrointest. Liver Physiol., 280, G68-G74.
26. MA, Z. & LEE, S.S. (1996). Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology, 24, 451-459.
27. MA, Z., LEE, S.S. & MEDDINGS, J.B. (1997). Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy. J. Hepatol., 26, 904-912.
28. MA, Z., MIYAMOTO, A. & LEE, S.S. (1996). Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology, 110, 1191-1198.
29. MA, Z., ZHANG, Y., HUET, P.M. & LEE, S.S. (1999). Differential effects of jaundice and cirrhosis on beta-adrenoceptor signaling in three rat models of cirrhotic cardiomyopathy. J. Hepatol., 30, 485-491.
30. MOESGAARD, B., PETERSEN, G., MORTENSEN, S.A. & HANSEN, H.S. (2002). Substantial species differences in relation to formation and degradation of N-acyl-ethanolamine phospholipids in heart tissue: an enzyme activity study. Comp. Biochem. Physiol. B, 131, 475-482.
31. MOLLER, S., BENDTSEN, F. & HENRIKSEN, J.H. (2001). Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis. Can. J. Gastroenterol., 15, 94-106.
32. MYERS, R.P. & LEE, S.S. (2000). Cirrhotic cardiomyopathy and liver transplantation. Liver Transplant., 6, S44-S52.
33. OTANI, H., OSHIRO, A., YAGI, M. & INAGAKI, C. (2001). Pertussis toxin-sensitive and -insensitive mechanisms of [alpha]1-adrenoceptor-mediated inotropic responses in rat heart. Eur. J. Pharmacol., 419, 249-252.
34. PAN, H.-L. & CHEN, S.-R. (2004). Sensing tissue ischemia: another new function for capsaicin receptors? Circulation, 110, 1826-1831.
35. PETROCELLIS, L.D., CASCIO, M.G. & MARZO, V.D. (2004). The endocannabinoid system: a general view and latest additions. Br. J. Pharmacol., 141, 765-774.
36. PRABHU, S.D., AZIMI, A. & FROSTO, T. (1999). Nitric oxide effects on myocardial function and force-interval relations: regulation of twitch duration. J. Mol. Cell Cardiol., 31, 2077-2085.
37. RAMOND, M.J., COMOY, E. & LEBREC, D. (1986). Alterations in isoprenaline sensitivity in patients with cirrhosis: evidence of abnormality of the sympathetic nervous activity. Br. J. Clin. Pharmacol., 21, 191-196.
38. RANDALL, M.D., HARRIS, D., KENDALL, D.A. & RALEVIC, V. (2002). Cardiovascular effects of cannabinoids. Pharmacol. Ther., 95, 191-202.
39. RAYES, N., BECHSTEIN, W.O., KECK, H., BLUMHARDT, G., LOHMANN, R. & NEUHAUS, P. (1995). Cause of death after liver transplantation: an analysis of 41 cases in 382 patients. Zentralbl. Chir., 120, 435-438.
40. ROS, J., CLARIA, J., TO-FIGUERAS, J., PLANAGUMA, A., CEJUDO-MARTIN, P., FERNANDEZ-VARO, G., MARTIN-RUIZ, R., ARROYO, V., RIVERA, F., RODES, J. & JIMENEZ, W. (2002). Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology, 122, 85-93.
41. ROSS, R.A. (2003). Anandamide and vanilloid TRPV1 receptors. Br. J. Pharmacol., 140, 790-801.
42. ROSS, R.A., BROCKIE, H.C., STEVENSON, L.A., MURPHY, V.L., TEMPLETON, F., MAKRIYANNIS, A. & PERTWEE, R.G. (1999). Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630. Br. J. Pharmacol., 126, 665-672.
43. RUIZ-DEL-ARBOL, L., URMAN, J., FERNANDEZ, J., GONZALEZ, M., NAVASA, M., MONESCILLO, A., ALBILLOS, A., JIMENEZ, W. & ARROYO, V. (2003). Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 38, 1210-1218.
44. SHAH, V. (2001). Portal hypertension and the hyperdynamic circulation: nitric oxide in a haze of cannabinoid smoke. Hepatology, 34, 1060-1061.
45. WILSON, R.I. & NICOLL, R.A. (2001). Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature, 410, 588-592.
46. WONG, H., ANDERSON, W.D., CHENG, T. & RIABOWOL, K.T. (1994). Monitoring mRNA expression by polymerase chain reaction: the primer-dropping method. Anal. Biochem., 223, 251-258.